Jpmorgan Chase & CO Dare Bioscience, Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 239 shares of DARE stock, worth $81. This represents 0.0% of its overall portfolio holdings.
Number of Shares
239
Previous 12,294
98.06%
Holding current value
$81
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DARE
# of Institutions
37Shares Held
6.86MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.45MShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA989KShares$336,3640.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny763KShares$259,3860.0% of portfolio
-
Black Rock Inc. New York, NY396KShares$134,6730.0% of portfolio
-
State Street Corp Boston, MA248KShares$84,2210.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $28.8M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...